Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Liraglutide | Liraglutide may increase the hypoglycemic activities of Insulin argine. |
| Metreleptin | Metreleptin may increase the hypoglycemic activities of Insulin argine. |
| Pioglitazone | The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin argine. |
| Pramlintide | Pramlintide may increase the hypoglycemic activities of Insulin argine. |
| Rosiglitazone | The risk or severity of congestive heart failure can be increased when Insulin argine is combined with Rosiglitazone. |
| Edetic acid | Edetic acid may increase the hypoglycemic activities of Insulin argine. |
| Esmolol | Esmolol may increase the hypoglycemic activities of Insulin argine. |
| Betaxolol | Betaxolol may increase the hypoglycemic activities of Insulin argine. |
| Metoprolol | Metoprolol may increase the hypoglycemic activities of Insulin argine. |
| Atenolol | Atenolol may increase the hypoglycemic activities of Insulin argine. |
| Timolol | Timolol may increase the hypoglycemic activities of Insulin argine. |
| Sotalol | Sotalol may increase the hypoglycemic activities of Insulin argine. |
| Propranolol | Propranolol may increase the hypoglycemic activities of Insulin argine. |
| Labetalol | Labetalol may increase the hypoglycemic activities of Insulin argine. |
| Bisoprolol | Bisoprolol may increase the hypoglycemic activities of Insulin argine. |
| Alprenolol | Alprenolol may increase the hypoglycemic activities of Insulin argine. |
| Pindolol | Pindolol may increase the hypoglycemic activities of Insulin argine. |
| Carvedilol | Carvedilol may increase the hypoglycemic activities of Insulin argine. |
| Propafenone | Propafenone may increase the hypoglycemic activities of Insulin argine. |
| Acebutolol | Acebutolol may increase the hypoglycemic activities of Insulin argine. |
| Nadolol | Nadolol may increase the hypoglycemic activities of Insulin argine. |
| Bevantolol | Bevantolol may increase the hypoglycemic activities of Insulin argine. |
| Practolol | Practolol may increase the hypoglycemic activities of Insulin argine. |
| Penbutolol | Penbutolol may increase the hypoglycemic activities of Insulin argine. |
| Oxprenolol | Oxprenolol may increase the hypoglycemic activities of Insulin argine. |
| Dexpropranolol | Dexpropranolol may increase the hypoglycemic activities of Insulin argine. |
| Celiprolol | Celiprolol may increase the hypoglycemic activities of Insulin argine. |
| Nebivolol | Nebivolol may increase the hypoglycemic activities of Insulin argine. |
| Bufuralol | Bufuralol may increase the hypoglycemic activities of Insulin argine. |
| Bopindolol | Bopindolol may increase the hypoglycemic activities of Insulin argine. |
| Bupranolol | Bupranolol may increase the hypoglycemic activities of Insulin argine. |
| Indenolol | Indenolol may increase the hypoglycemic activities of Insulin argine. |
| Arotinolol | Arotinolol may increase the hypoglycemic activities of Insulin argine. |
| Levobetaxolol | Levobetaxolol may increase the hypoglycemic activities of Insulin argine. |
| Talinolol | Talinolol may increase the hypoglycemic activities of Insulin argine. |
| Anisodamine | Anisodamine may increase the hypoglycemic activities of Insulin argine. |
| Bucindolol | Bucindolol may increase the hypoglycemic activities of Insulin argine. |
| Esatenolol | Esatenolol may increase the hypoglycemic activities of Insulin argine. |
| Cloranolol | Cloranolol may increase the hypoglycemic activities of Insulin argine. |
| Mepindolol | Mepindolol may increase the hypoglycemic activities of Insulin argine. |
| Epanolol | Epanolol may increase the hypoglycemic activities of Insulin argine. |
| Tertatolol | Tertatolol may increase the hypoglycemic activities of Insulin argine. |
| Landiolol | Landiolol may increase the hypoglycemic activities of Insulin argine. |
| Sitagliptin | The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Insulin argine. |
| Vildagliptin | The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin argine. |
| AMG-222 | The risk or severity of hypoglycemia can be increased when AMG-222 is combined with Insulin argine. |
| Bisegliptin | The risk or severity of hypoglycemia can be increased when Bisegliptin is combined with Insulin argine. |
| Alogliptin | The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Insulin argine. |
| Saxagliptin | The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Insulin argine. |
| Gosogliptin | The risk or severity of hypoglycemia can be increased when Gosogliptin is combined with Insulin argine. |
| Linagliptin | The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Insulin argine. |
| Dutogliptin | The risk or severity of hypoglycemia can be increased when Dutogliptin is combined with Insulin argine. |
| Teneligliptin | The risk or severity of hypoglycemia can be increased when Teneligliptin is combined with Insulin argine. |
| Omarigliptin | The risk or severity of hypoglycemia can be increased when Omarigliptin is combined with Insulin argine. |
| Carmegliptin | The risk or severity of hypoglycemia can be increased when Carmegliptin is combined with Insulin argine. |
| Gemigliptin | The risk or severity of hypoglycemia can be increased when Gemigliptin is combined with Insulin argine. |
| Anagliptin | The risk or severity of hypoglycemia can be increased when Anagliptin is combined with Insulin argine. |
| Evogliptin | The risk or severity of hypoglycemia can be increased when Evogliptin is combined with Insulin argine. |
| Exenatide | The risk or severity of hypoglycemia can be increased when Exenatide is combined with Insulin argine. |
| Albiglutide | The risk or severity of hypoglycemia can be increased when Albiglutide is combined with Insulin argine. |
| Dulaglutide | The risk or severity of hypoglycemia can be increased when Dulaglutide is combined with Insulin argine. |
| Lixisenatide | The risk or severity of hypoglycemia can be increased when Lixisenatide is combined with Insulin argine. |
| Semaglutide | The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Insulin argine. |
| Taspoglutide | The risk or severity of hypoglycemia can be increased when Taspoglutide is combined with Insulin argine. |
| Macimorelin | The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin argine. |
| Metformin | The risk or severity of adverse effects can be increased when Insulin argine is combined with Metformin. |
| Testosterone undecanoate | Testosterone undecanoate may increase the hypoglycemic activities of Insulin argine. |
| Glucagon | The therapeutic efficacy of Insulin argine can be decreased when used in combination with Glucagon. |
| Metoclopramide | The therapeutic efficacy of Insulin argine can be increased when used in combination with Metoclopramide. |
| Tirzepatide | The risk or severity of hypoglycemia can be increased when Insulin argine is combined with Tirzepatide. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin argine. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin argine. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin argine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Insulin pork is combined with Insulin argine. |
| Troglitazone | The risk or severity of hypoglycemia can be increased when Troglitazone is combined with Insulin argine. |
| Glimepiride | The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin argine. |
| Sulfisoxazole | The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Insulin argine. |
| Disopyramide | The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Insulin argine. |
| Acarbose | The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin argine. |
| Sulfadiazine | The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Insulin argine. |
| Acetohexamide | The risk or severity of hypoglycemia can be increased when Acetohexamide is combined with Insulin argine. |
| Quinine | The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin argine. |
| Miglitol | The risk or severity of hypoglycemia can be increased when Miglitol is combined with Insulin argine. |
| Chlorpropamide | The risk or severity of hypoglycemia can be increased when Chlorpropamide is combined with Insulin argine. |
| Nateglinide | The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Insulin argine. |
| Pentamidine | The risk or severity of hypoglycemia can be increased when Pentamidine is combined with Insulin argine. |
| Mifepristone | The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Insulin argine. |
| Tolazamide | The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Insulin argine. |
| Repaglinide | The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Insulin argine. |
| Phenformin | The risk or severity of hypoglycemia can be increased when Phenformin is combined with Insulin argine. |
| Sulfamethoxazole | The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Insulin argine. |
| Glyburide | The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin argine. |
| Glipizide | The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin argine. |
| Gliclazide | The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin argine. |
| Tolbutamide | The risk or severity of hypoglycemia can be increased when Tolbutamide is combined with Insulin argine. |
| Bromocriptine | The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Insulin argine. |
| Gliquidone | The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin argine. |
| Mitiglinide | The risk or severity of hypoglycemia can be increased when Mitiglinide is combined with Insulin argine. |
| Sunitinib | The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Insulin argine. |
| Mecasermin | The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Insulin argine. |